@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
ns1:cause .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T19:36:14.960828"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "significant reduction in the release of TNFα , IL-6 , IL-1β and IL-8" .
rdf:OBJECT-POSITION rdfs:label "28"^^xsd:integer .
rdf:PREDICATE rdfs:label "caused" .
rdf:PREDICATE-POSITION rdfs:label "[51]" .
rdf:SUBJECT rdfs:label "pre-treatment with dexamethasone ( 100 nM )" .
rdf:SUBJECT-POSITION rdfs:label "3"^^xsd:integer .
rdfs:ABSTRACT-UID ns3:50 "z9oyrkzt" .
rdfs:SENTENCE rdfs:label "However, pre-treatment with dexamethasone (100 nM) caused significant reduction in the release of TNFα, IL-6, IL-1β and IL-8." .
rdfs:TRIPLE-UID ns2:z9oyrkzt-TRIPLE-ABSTRACT-1 "z9oyrkzt-TRIPLE-ABSTRACT-1" .
rdfs:label "treatment" .
rdfs:label "release" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "Dg+BraOu+EMIDzrhYRbDPoLBqiWMeH1appdKWuSjQifmyidV9OvVrtByUUHoxJyowlQz+u8m2eDznD78iOhZ50h98azoTbcXe0XTVyqWkXIrKzrhmnwX4V7ubIrKFis3nbpT97xNZPhIJLbUEabqp2rniVPcUKR0pUTCO3tp3sM=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T19:36:14.960828"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}